Publications by authors named "Jesus D Anampa"

Claim this Profile
I
Impact of hospital volume on mortality in adult women over 65 with triple-negative breast cancer.
Barnabas T Obeng-Gyasi, Demond L Handley, Mohamed I Elsaid, Eric Schupp, Daniel G Stover, Jesus D Anampa

J Geriatr Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemotherapy in Lymph Node-Negative, T1 Triple-Negative Breast Cancer.
Jesus D Anampa, Alvaro Alvarez Soto, Rachel B Jimenez, Samilia Obeng-Gyasi, Xiaonan Xue

Cancer Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Chatbots and Their Responses to Most Searched Spanish Cancer Questions.
En Cheng, Jesus D Anampa, Carolina Bernabe-Ramirez, Juan Lin, Xiaonan Xue

Cancer Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and Benefit of Neoadjuvant Versus Adjuvant Chemotherapy in Node-Negative, T1 Triple Negative Breast Cancer.
Jesus D Anampa, Alvaro Alvarez Soto, Shuwen Lin, Ana M Bernal, Xiaonan Xue

Clin Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy.
Samilia Obeng-Gyasi, Demond Handley, Jesse J Plascak, Jesus D Anampa, J C Chen

Cancer Epidemiol Biomarkers Prev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Incidence of Invasive Lobular Carcinoma of the Breast by Race: Patterns by Age, Cancer Stage, and Socioeconomic Factors in the United States, 1992-2019.
Ryann M Quinn, Ana M Bernal, Sun Young Oh, Jesus D Anampa

Clin Breast Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial disparities in treatment and outcomes between Hispanic and non-Hispanic black women with triple-negative breast cancer.
Jesus D Anampa, Alvaro Alvarez Soto, Ana M Bernal, Ana Acuna-Villaorduna

Breast Cancer Res Treat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between allostatic load and lymphedema in breast cancer survivors.
Barnabas Obeng-Gyasi, Yevgeniya Gokun, Mohamed I Elsaid, J C Chen, Barbara L Andersen, Jesus D Anampa

Support Care Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and Survival Differences between Patients with Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma of the Breast.
Jesus D Anampa, Shuwen Lin, Samilia Obeng-Gyasi, Xiaonan Xue

Cancer Epidemiol Biomarkers Prev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer.
Jesus D Anampa, Daniel L Flynn, Cynthia Leary, Sun Oh, Xiaonan Xue

Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
Walter Carbajal-Ochoa, Daniela C Bravo-Solarte, Ana M Bernal, Jesus D Anampa

Breast Cancer Res Treat· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer.
Daniela C Bravo-Solarte, Frank Zhang, Jesus D Anampa

Clin Breast Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
Walter H Carbajal-Ochoa, Devin Johnson, Alvaro Alvarez, Ana M Bernal, Jesus D Anampa

Breast Cancer Res Treat· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of systemic therapy for early stage triple-negative breast cancer.
Jin-Yu Lu, Alvaro Alvarez Soto, Jesus D Anampa

Expert Opin Pharmacother· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors.
Ashley Schreier, Laura Munoz-Arcos, Alvaro Alvarez, Joseph A Sparano, Jesus D Anampa

Breast Cancer Res Treat· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer.
Lauren C Shapiro, Astha Thakkar, Sean T Campbell, Stefanie K Forest, Kith Pradhan, Jesus D Anampa

Cancer Cell· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying the Hippocratic Oath in breast cancer-The case for promoting prevention.
Jesus D Anampa, Maureen P McEvoy, Sheldon Feldman, Joseph A Sparano

Breast J· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia.
Luis A Carvajal, Daniela Ben Neriah, Adrien Senecal, Lumie Benard, Victor Thiruthuvanathan, Jesus D Anampa

Sci Transl Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis